Offer - Urjas Oil for just ₹ 1 X
Aspitrate 30/150 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Angina, Fever, Heart Attack. Other than this, Aspitrate 30/150 Capsule has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Aspitrate 30/150 Capsule depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Aspitrate 30/150 Capsule include Headache, Dizziness, Flushing. Apart from the aforementioned side effects, Aspitrate 30/150 Capsule can also lead to other problems, which have been listed below. These side effects of Aspitrate 30/150 Capsule are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Aspitrate 30/150 Capsule has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Aspitrate 30/150 Capsule related warnings talks about Aspitrate 30/150 Capsule's effects on the liver, heart and kidney.
Aspitrate 30/150 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Aspitrate 30/150 Capsule in conditions like Low Blood Pressure (Hypotension), Anemia, Asthma. Other conditions have been mentioned below in the Aspitrate 30/150 Capsule contraindications section.
Additionally, Aspitrate 30/150 Capsule may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Aspitrate 30/150 Capsule is safe while driving, and is is addictive in nature.
Aspitrate 30/150 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Aspitrate 30/150 Capsule safe for pregnant women?
Aspitrate shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Aspitrate 30/150 Capsule safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Aspitrate. It should only be taken after medical advice.
What is the effect of Aspitrate 30/150 Capsule on the Kidneys?
Aspitrate may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Aspitrate 30/150 Capsule on the Liver?
Aspitrate is completely safe for the liver.
What is the effect of Aspitrate 30/150 Capsule on the Heart?
Aspitrate can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Aspitrate 30/150 Capsule unless your doctor advises you to do so -
Is this Aspitrate 30/150 Capsule habit forming or addictive?
No, there is no any evidence that Aspitrate 30/150 Capsule is addictive.
Interaction between Food and Aspitrate 30/150 Capsule
There is no information on the effects of taking Aspitrate 30/150 Capsule with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Aspitrate 30/150 Capsule
Information about the interaction of Aspitrate 30/150 Capsule and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; monoket® (isosorbide mononitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 716-718
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194